Ephrin B reverse signaling in endothelial cells
Ephrin B 在内皮细胞中逆转信号
基本信息
- 批准号:6691219
- 负责人:
- 金额:$ 4.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-01 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:CHO cells angiogenesis angiogenesis factor binding proteins biological signal transduction cell adhesion cell migration cell proliferation endocytosis ligands postdoctoral investigator protein protein interaction protein structure function protein tyrosine kinase receptor binding transcription factor vascular endothelium
项目摘要
DESCRIPTION (provided by applicant): Angiogenesis is a multi-step process requiring signals to induce endothelial cell proliferation, migration, and assembly. The Eph receptor tyrosine kinases (RTKs) and their ligands, ephrins, are important mediators of endothelial cell migration and attachment. As membrane tethered ligands, ephrins are capable of transmitting signals bi-directionally. Previous studies from our laboratory have shown that ephrin-B1 is activated by a soluble form of the EphB1-Fc receptor which lacks a cytoplasmic domain and thus is incapable of transmitting forward signals. In addition, soluble EphB1-Fc stimulation of endothelial cells induces cell migration, attachment, and in vivo angiogenesis. These cellular changes require the PDZ binding domain of ephrin B1. Based on these data, we hypothesize that (1) ephrin-B1 reverse signaling is mediated by PDZ adapter proteins through which downstream signaling pathways are activated, and (2) internalization of surface ephrin-B1 represents a mechanism by which ephrin-B1-mediated reverse signaling is regulated. To test these hypotheses, we propose to investigate signaling components downstream of ephrin-B1 by identifying ephrin B1 adapter proteins and pathways that transduce signals affecting endothelial cell migration and adhesion. We will also determine the role of ephrin-B1 internalization in regulating ehrin B1 activation and signal transduction.
描述(由申请人提供):血管生成是一个多步骤过程,需要信号来诱导内皮细胞增殖、迁移和组装。Eph受体酪氨酸激酶(RTK)及其配体ephrin是内皮细胞迁移和附着的重要介质。作为膜栓系配体,肝配蛋白能够双向传递信号。我们实验室以前的研究表明,肝配蛋白-B1被缺乏胞质结构域的EphB 1-Fc受体的可溶形式激活,因此不能传递正向信号。此外,内皮细胞的可溶性EphB 1-Fc刺激诱导细胞迁移、附着和体内血管生成。这些细胞变化需要肝配蛋白B1的PDZ结合结构域。基于这些数据,我们假设(1)肝配蛋白-B1反向信号传导是由PDZ衔接蛋白介导的,通过PDZ衔接蛋白激活下游信号传导途径,以及(2)表面肝配蛋白-B1的内化代表了肝配蛋白-B1介导的反向信号传导被调节的机制。为了验证这些假设,我们建议通过鉴定肝配蛋白B1接头蛋白和影响内皮细胞迁移和粘附的信号传导途径来研究肝配蛋白B1下游的信号传导成分。我们还将确定ephrin-B1内化在调节ephrin B1激活和信号转导中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MONICA A PARKER其他文献
MONICA A PARKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MONICA A PARKER', 18)}}的其他基金
Ephrin B reverse signaling in endothelian cells
内皮细胞中的 Ephrin B 反向信号传导
- 批准号:
6792211 - 财政年份:2003
- 资助金额:
$ 4.16万 - 项目类别:
相似国自然基金
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
- 批准号:81200692
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of oncolytic virus targeting tumor angiogenesis factor
靶向肿瘤血管生成因子的溶瘤病毒的研制
- 批准号:
20K09900 - 财政年份:2020
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A pathophysiological significance of a novel angiogenesis factor in diabetic kidney disease and chronic kidney disease
新型血管生成因子在糖尿病肾病和慢性肾病中的病理生理学意义
- 批准号:
19K08730 - 财政年份:2019
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification and functional analysis of target microRNAs of angiogenesis factor regulating endochondral ossification
血管生成因子调节软骨内骨化的靶标microRNA的鉴定及功能分析
- 批准号:
25713064 - 财政年份:2013
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Investigation of mechanism of angiogenesis factor, angiogenin, as a molecular target against cancer-induced bone destruction
研究血管生成因子血管生成素作为对抗癌症引起的骨破坏的分子靶标的机制
- 批准号:
20390516 - 财政年份:2008
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Search of natural compound activating endogenous anti-angiogenesis factor as an anti-cancer agent.
寻找激活内源性抗血管生成因子的天然化合物作为抗癌剂。
- 批准号:
20510209 - 财政年份:2008
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Anti-angiogenesis therapy by transplantation of cells expressing anti-angiogenesis factor established by gene transductions
通过移植表达通过基因转导建立的抗血管生成因子的细胞进行抗血管生成治疗
- 批准号:
19390344 - 财政年份:2007
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of inhibitors for a angiogenesis factor CTGF and its application for angiogenetic diseases
血管生成因子CTGF抑制剂的研制及其在血管生成疾病中的应用
- 批准号:
10557165 - 财政年份:1998
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The endogenous growth and angiogenesis factor in the placenta and the placental bed.
胎盘和胎盘床的内源性生长和血管生成因子。
- 批准号:
62570747 - 财政年份:1987
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Investigation of angiogenesis factor. - Basic research for a treatment of brain ischemic diseases including moyamoya disease. -
血管生成因子的研究。
- 批准号:
61570688 - 财政年份:1986
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)